Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for January 2008
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

PR firm Chamberlain opens European office
London chosen for new location..(more)

 Avastin launched in UK for kidney cancer
The drug's first-line indication gives it an edge over rivals..(more)

 Pfizer sales dip during year of restructuring
Company hit by patent expiries and difficult market conditions..(more)

 Avandia hit by further restrictions
Safety warnings tightened up and new contraindication added..(more)

 Latest news from Datamonitor
Clinical and product roundup..(more)

 Genmab's MabThera rival enters phase III
HuMax could be on the market by mid-2009..(more)

 NICE contributes to government's anti-obesity vision
Recommends more new cycle paths, pedestrianised areas, and attractive staircases in the workplace..(more)

 Athena picks up account for key Bayer Schering product
Agency will handle UK PR for anti-coagulant Xarelto ..(more)

 Pharma companies raided over alleged generic blocking
European Commission to investigate manufacturers of branded and generic medicines..(more)

 Roche invests in Germany and Swiss biotech sites
Aims to safeguard and expand production..(more)

 AstraZeneca puts Crestor head-to-head with Lipitor
Global trial will examine drugs' impact on atherosclerosis..(more)

 GSK's allergy treatment Avamys approved in Europe
Drug is a once-daily corticosteroid nasal spray for allergic rhinitis..(more)

 European research service to track technology adoption by physicians
Taking the Pulse Europe will cover the five main markets..(more)

 MPs call for more generic prescribing
Industry marketing also criticised as drugs bill rises..(more)

 US problems hit Novartis
Generic competitors take billions from company revenues..(more)

 Stakeholders clash over European patient information
Draft legislation is due in October..(more)

 Pfizer boosts pipeline with biotech tissue deal
Adds product candidate for patients with cartilage diseases like osteoarthritis..(more)

 Latest news from Datamonitor
Clinical and product roundup..(more)

 Europe unites with Canada on safety regulation
Agreement aims to strength public health protection..(more)

 Cancer Research invests £10m in drug discovery
Grants support research into new and targeted small molecule treatments..(more)

 Sharp fall in candidates taking ABPI exam
Numbers sitting the test almost halved in the last two years..(more)

 Genentech growth to slow in 2008
Short term prospects hit by breast cancer rejection for Avastin..(more)

 MPs call for ban on biosimilars
Parliamentary panel questions their safety..(more)

 Virgin launches GP service
First Virgin Healthcare centre opens later this year..(more)

 Government funds superbug nurses in every hospital
But two new infection targets for the NHS..(more)

 Animal toxicity test set to be scrapped
Number of rodents used in pre-clinical testing will be reduced..(more)

 Government seeks 10% cut on NHS medicines bill
Minister reveals plans to media before industry..(more)

 Atripla approved in Europe
First three-in-one HIV drug ready for launch..(more)

 Lechleiter to be new Lilly chief
Taurel steps down after 10 years..(more)

 GSK claims Seretide superior to Spiriva
But clear advantage still out of reach..(more)

 Delayed Galvus cleared for 2008 European launch
CHMP approves revised labelling..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.